The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 518.00
Bid: 522.00
Ask: 523.00
Change: -7.00 (-1.33%)
Spread: 1.00 (0.192%)
Open: 531.00
High: 536.50
Low: 518.00
Prev. Close: 525.00
DRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

30 May 2018 17:14

RNS Number : 7451P
Drax Group PLC
30 May 2018
 

 

Transactions in own shares

 

Drax Group plc (the Company) announces today it has purchased the following number of its ordinary shares of 11 16/29 pence each through J.P. Morgan Securities plc.

 

Date of purchase:

30 May 2018

 

Aggregate number of ordinary shares purchased:

79,716

 

Lowest price paid per share:

326.80000

 

Highest price paid per share:

330.80000

 

Average price paid per share:

328.42468

 

The Company intends to hold the purchased shares in treasury.

 

Since 20 April 2018, the Company has purchased 2,166,491 shares at a cost (including dealing and associated costs) of £7,111,933.16.

 

Following the above transaction, the Company holds 2,166,491, of its ordinary shares in treasury and has 404,887,059 ordinary shares in issue (excluding treasury shares).

 

The table below contains detailed information about the purchases made as part of the buyback programme.

 

Schedule of Purchases

 

Shares purchased:

79,716 (ISIN: GB00B1VNSX38)

 

Date of purchases:

30 May 2018

 

Investment firm:

J.P. Morgan Securities plc

 

Aggregate information:

Venue

Volume-weighted average price (GBp)

Aggregated volume

Lowest price per share (GBp)

Highest price per share (GBp)

London Stock Exchange

328.42468

79,716

326.80000

330.80000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSEAKSEDFAPEFF
Date   Source Headline
15th Oct 20202:57 pmRNSHolding(s) in Company
15th Oct 20202:41 pmRNSHolding(s) in Company
14th Oct 20205:31 pmRNSHolding(s) in Company
14th Oct 20205:29 pmRNSHolding(s) in Company
14th Oct 20205:28 pmRNSHolding(s) in Company
5th Oct 20204:37 pmRNSBlock listing Interim Review - Sharesave Plan
5th Oct 20204:33 pmRNSBlock listing Interim Review - PSP
5th Oct 20204:24 pmRNSBlock listing Interim Review - Bonus Matching Plan
1st Oct 20202:46 pmRNSTotal Voting Rights
14th Sep 20202:04 pmRNSInfrastructure debt facility
1st Sep 20204:45 pmRNSTotal Voting Rights
28th Aug 20209:00 amRNSHolding(s) in Company
3rd Aug 20205:21 pmRNSTotal Voting Rights
31st Jul 202011:00 amRNSDirector/PDMR Shareholding
30th Jul 202010:48 amRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSHalf-year Report
21st Jul 202012:00 pmRNSNotice of Half Year 2020 Financial Results
17th Jul 20209:33 amRNSHolding(s) in Company
15th Jul 202010:39 amRNSHolding(s) in Company
9th Jul 20203:57 pmRNSHolding(s) in Company
7th Jul 20209:57 amRNSHolding(s) in Company
1st Jul 20202:26 pmRNSTotal Voting Rights
25th Jun 202010:57 amRNSHolding(s) in Company
23rd Jun 20202:34 pmRNSHolding(s) in Company
15th Jun 20202:21 pmRNSHolding(s) in Company
12th Jun 202011:54 amRNSHolding(s) in Company
12th Jun 20207:00 amRNS£125 million ESG facility extended to 2025
9th Jun 20203:15 pmRNSDisclosure of rights attached to equity securities
3rd Jun 20204:01 pmRNSHolding(s) in Company
1st Jun 202010:43 amRNSTotal Voting Rights
27th May 20202:30 pmRNSDirector/PDMR Shareholding
15th May 20203:00 pmRNSDirector/PDMR Shareholding
14th May 20209:00 amRNSHolding(s) in Company
11th May 20208:45 amRNSHolding(s) in Company
11th May 20207:00 amRNSDirector/PDMR Shareholding
1st May 20209:00 amRNSTotal Voting Rights
27th Apr 20209:37 amRNSHolding(s) in Company
22nd Apr 202012:45 pmRNSResult of AGM
22nd Apr 20209:00 amRNSHolding(s) in Company
22nd Apr 20207:00 amRNSTrading Update
17th Apr 20209:00 amRNSDirector/PDMR Shareholding
15th Apr 20207:06 amRNSNotice of AGM
9th Apr 20204:28 pmRNSAdditional Listing
8th Apr 20207:00 amRNSDirectorate Change
6th Apr 20204:29 pmRNSRemuneration Policy 2020 – EPS Condition
6th Apr 202011:53 amRNSBlock listing Interim Review - Bonus Matching Plan
6th Apr 202011:51 amRNSBlock listing Interim Review - Sharesave Plan
3rd Apr 20203:35 pmRNSDirector/PDMR Shareholding
1st Apr 20209:00 amRNSDirector/PDMR Shareholding
1st Apr 20208:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.